Comment: SABCS 2014 Highlights

Comment: Reducing fat intake reduces death rates in some breast cancer patients

Comment: Fulvestrant improves survival over anastrozole for patients with advanced breast cancer

Comment: Multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ

Comment: BOLERO-1 reports HER2-positive breast cancer latest PFS data

New IMRT techniques could be tissue-sparing and promote dosage conformity in breast cancer

Tamoxifen lowered breast cancer rates among high-risk women

Fulvestrant versus anastrozole in patients with advanced breast cancer

Reducing fat intake reduces death rates in some breast cancer patients

Recurrence risk could be predicted by a multigene test in ductal carcinoma breast cancer

Breast cancer in men and women has different biological characteristics and outcomes

PD-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer

Magnetic nanotechnology for the localisation of non-palpable breast cancers and concurrent sentinel node biopsy

Combination of eribulin and capecitabine provides clinical benefit for women with metastatic breast cancer

Ovarian suppression with tamoxifen reduced recurrence for some women with premenopausal breast cancer

Comment: Impact of combined bevacizumab and presurgery chemo varies by subtype

Adding ultrasound to routine mammography improves cancer detection in dense breasts

High tumour immune cell levels may help screen HER2-positive breast cancer patients for chemo

Comment: Combining tamoxifen with ovarian suppression reduced recurrence of some breast cancers

BOLERO-1 reports HER2-positive breast cancer latest PFS data

Comment: Tamoxifen lowered breast cancer rates among high-risk women

Impact of adding bevacizumab to presurgery chemo for triple-negative breast cancer varies with subtype

Fulvestrant improves survival over anastrozole for patients with advanced breast cancer

Progression-free survival results from BOLERO-1 trial

Lowering dietary fat intake reduces death rates in some women with breast cancer

Multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ

Ovarian suppression with tamoxifen reduced recurrence in some premenopausal breast cancer cases

Comment: Capecitabine for elderly early-stage breast cancer

Capecitabine monotherapy does not improve survival in elderly patients with early-stage breast cancer

Impact of adding bevacizumab to presurgery chemo for triple-negative breast cancer varies with subtype

Capecitabine monotherapy does not improve survival in elderly patients with early-stage breast cancer

IBIS-I trial: tamoxifen lowered breast cancer rates among high-risk women